Literature DB >> 16033915

Nijmegen breakage syndrome (NBS) with neurological abnormalities and without chromosomal instability.

E Seemanová1, K Sperling, H Neitzel, R Varon, J Hadac, O Butova, E Schröck, P Seeman, M Digweed.   

Abstract

BACKGROUND: Nijmegen breakage syndrome (NBS) is an autosomal recessive chromosomal instability disorder with hypersensitivity to ionising radiation. The clinical phenotype is characterised by congenital microcephaly, mild dysmorphic facial appearance, growth retardation, immunodeficiency, and greatly increased risk for lymphoreticular malignancy. Most NBS patients are of Slavic origin and homozygous for the founder mutation 657del5. The frequency of 657del5 heterozygotes in the Czech population is 1:150. Recently, another NBS1 mutation, 643C>T(R215W), with uncertain pathogenicity was found to have higher frequency among tumour patients of Slavic origin than in controls. This alteration results in the substitution of the basic amino acid arginine with the non-polar tryptophan and thus could potentially interfere with the function of the NBS1 protein, nibrin. METHODS AND
RESULTS: Children with congenital microcephaly are routinely tested for the 657del5 mutation in the Czech and Slovak Republics. Here, we describe for the first time a severe form of NBS without chromosomal instability in monozygotic twin brothers with profound congenital microcephaly and developmental delay who are compound heterozygotes for the 657del5 and 643C>T(R215W) NBS1 mutations. Both children showed reduced expression of full length nibrin when compared with a control and a heterozygote for the 657del5 mutation. Radiation response processes such as phosphorylation of ATM and phosphorylation/stabilisation of p53, which are promoted by NBS1, are strongly reduced in cells from these patients.
CONCLUSIONS: Interestingly, the patients are more severely affected than classical NBS patients. Consequently, we postulate that homozygosity for the 643C>T(R215W) mutation will also lead to a, possibly very, severe disease phenotype.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16033915      PMCID: PMC2563240          DOI: 10.1136/jmg.2005.035287

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  29 in total

1.  Atypical clinical picture of the Nijmegen breakage syndrome associated with developmental abnormalities of the brain.

Authors:  K H Chrzanowska; M Stumm; M Bekiesiska-Figatowska; R Varon; M Biaecka; H Gregorek; J Michakiewicz; M Krajewska-Walasek; S Jówiak; A Reis
Journal:  J Med Genet       Date:  2001-01       Impact factor: 6.318

2.  An alternative mode of translation permits production of a variant NBS1 protein from the common Nijmegen breakage syndrome allele.

Authors:  R S Maser; R Zinkel; J H Petrini
Journal:  Nat Genet       Date:  2001-04       Impact factor: 38.330

3.  Clinical ascertainment of Nijmegen breakage syndrome (NBS) and prevalence of the major mutation, 657del5, in three Slav populations.

Authors:  R Varon; E Seemanova; K Chrzanowska; O Hnateyko; D Piekutowska-Abramczuk; M Krajewska-Walasek; J Sykut-Cegielska; K Sperling; A Reis
Journal:  Eur J Hum Genet       Date:  2000-11       Impact factor: 4.246

4.  Mutations in the Nijmegen Breakage Syndrome gene (NBS1) in childhood acute lymphoblastic leukemia (ALL).

Authors:  R Varon; A Reis; G Henze; H G von Einsiedel; K Sperling; K Seeger
Journal:  Cancer Res       Date:  2001-05-01       Impact factor: 12.701

5.  Targeted disruption of the Nijmegen breakage syndrome gene NBS1 leads to early embryonic lethality in mice.

Authors:  J Zhu; S Petersen; L Tessarollo; A Nussenzweig
Journal:  Curr Biol       Date:  2001-01-23       Impact factor: 10.834

Review 6.  Nijmegen breakage syndrome. The International Nijmegen Breakage Syndrome Study Group.

Authors: 
Journal:  Arch Dis Child       Date:  2000-05       Impact factor: 3.791

7.  Cranial MRI in the Nijmegen breakage syndrome.

Authors:  M Bekiesińska-Figatowska; K H Chrzanowska; J Sikorska; J Walecki; M Krajewska-Walasek; S Jóźwiak; W J Kleijer
Journal:  Neuroradiology       Date:  2000-01       Impact factor: 2.804

8.  Nijmegen breakage syndrome: clinical characteristics and mutation analysis in eight unrelated Russian families.

Authors:  Igor B Resnick; Irina Kondratenko; Oleg Togoev; Natalia Vasserman; Irena Shagina; Oleg Evgrafov; Svetlana Tverskaya; Karen M Cerosaletti; Richard A Gatti; Patrick Concannon
Journal:  J Pediatr       Date:  2002-03       Impact factor: 4.406

9.  Nbs1 promotes ATM dependent phosphorylation events including those required for G1/S arrest.

Authors:  Pierre-Marie Girard; Enriqueta Riballo; Adrian C Begg; Alastair Waugh; Penny A Jeggo
Journal:  Oncogene       Date:  2002-06-20       Impact factor: 9.867

10.  Chk2 activation dependence on Nbs1 after DNA damage.

Authors:  G Buscemi; C Savio; L Zannini; F Miccichè; D Masnada; M Nakanishi; H Tauchi; K Komatsu; S Mizutani; K Khanna; P Chen; P Concannon; L Chessa; D Delia
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

View more
  14 in total

1.  Spectrum and Prevalence of Pathogenic Variants in Ovarian Cancer Susceptibility Genes in a Group of 333 Patients.

Authors:  Magdalena Koczkowska; Natalia Krawczynska; Maciej Stukan; Alina Kuzniacka; Izabela Brozek; Marcin Sniadecki; Jaroslaw Debniak; Dariusz Wydra; Wojciech Biernat; Piotr Kozlowski; Janusz Limon; Bartosz Wasag; Magdalena Ratajska
Journal:  Cancers (Basel)       Date:  2018-11-14       Impact factor: 6.639

2.  Heterozygous p.I171V mutation of the NBN gene as a risk factor for lung cancer development.

Authors:  Ewelina Maria Kałużna; Jolanta Rembowska; Iwona Ziółkowska-Suchanek; Bogna Świątek-Kościelna; Piotr Gabryel; Wojciech Dyszkiewicz; Jerzy Stanisław Nowak
Journal:  Oncol Lett       Date:  2015-09-17       Impact factor: 2.967

3.  Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment.

Authors:  Allison W Kurian; Emily E Hare; Meredith A Mills; Kerry E Kingham; Lisa McPherson; Alice S Whittemore; Valerie McGuire; Uri Ladabaum; Yuya Kobayashi; Stephen E Lincoln; Michele Cargill; James M Ford
Journal:  J Clin Oncol       Date:  2014-04-14       Impact factor: 44.544

4.  Nbs1 flexibly tethers Ctp1 and Mre11-Rad50 to coordinate DNA double-strand break processing and repair.

Authors:  R Scott Williams; Gerald E Dodson; Oliver Limbo; Yoshiki Yamada; Jessica S Williams; Grant Guenther; Scott Classen; J N Mark Glover; Hiroshi Iwasaki; Paul Russell; John A Tainer
Journal:  Cell       Date:  2009-10-02       Impact factor: 41.582

Review 5.  Nijmegen breakage syndrome (NBS).

Authors:  Krystyna H Chrzanowska; Hanna Gregorek; Bożenna Dembowska-Bagińska; Maria A Kalina; Martin Digweed
Journal:  Orphanet J Rare Dis       Date:  2012-02-28       Impact factor: 4.123

6.  NBN Gene Polymorphisms and Cancer Susceptibility: A Systemic Review.

Authors:  Francesco Berardinelli; Alessandra di Masi; Antonio Antoccia
Journal:  Curr Genomics       Date:  2013-11       Impact factor: 2.236

7.  Functional deficiency of NBN, the Nijmegen breakage syndrome protein, in a p.R215W mutant breast cancer cell line.

Authors:  Bianca Schröder-Heurich; Natalia Bogdanova; Britta Wieland; Xiaoxi Xie; Monika Noskowicz; Tjoung-Won Park-Simon; Peter Hillemanns; Hans Christiansen; Thilo Dörk
Journal:  BMC Cancer       Date:  2014-06-13       Impact factor: 4.430

8.  NBS1 Heterozygosity and Cancer Risk.

Authors:  Alessandra di Masi; Antonio Antoccia
Journal:  Curr Genomics       Date:  2008-06       Impact factor: 2.236

9.  Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer.

Authors:  Sylvie Desjardins; Joly Charles Beauparlant; Yvan Labrie; Geneviève Ouellette; Francine Durocher
Journal:  BMC Cancer       Date:  2009-06-12       Impact factor: 4.430

10.  Nbn and atm cooperate in a tissue and developmental stage-specific manner to prevent double strand breaks and apoptosis in developing brain and eye.

Authors:  Paulo M G Rodrigues; Paulius Grigaravicius; Martina Remus; Gabriel R Cavalheiro; Anielle L Gomes; Maurício Rocha-Martins; Mauricio R Martins; Lucien Frappart; David Reuss; Peter J McKinnon; Andreas von Deimling; Rodrigo A P Martins; Pierre-Olivier Frappart
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.